Evidence map›Paper›PMID 38531104›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali.

M'Bouye Doucoure, Amatigue Zeguime, Amadou Niangaly, Merepen A Guindo, Justin Y A Doritchamou, Mahamadoun H Assadou, Abdoulaye Katile, Moussa B Kanoute, Sidiki Perou, Adama Ouattara and 20 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 3 institutions in 2 countries.

M'Bouye DoucoureMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Amatigue ZeguimeMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Amadou NiangalyMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Merepen A GuindoMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Justin Y A DoritchamouLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Mahamadoun H AssadouMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Abdoulaye KatileMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Moussa B KanouteMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Sidiki PerouMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Adama OuattaraMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Sintry SanogoMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Boucary OuologuemMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Souleymane TraoreMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Bakary DaoMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Drissa DembeleMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Mamady KoneMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Bourama KamateMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Kourane SissokoMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Seydou SankareMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Sadio DiarraMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Amagana DoloMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Mahamadou S SissokoMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Jennifer C C HumeLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
David CookLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Sara A HealyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
J Patrick GorresLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Boubacar TraoréMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Jordyn GamielDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Patrick E DuffyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Issaka SagaraMalaria Research and Training Center, International Center for Excellence in Research-MALI, University of Sciences, Techniques and Technologies of Bamako, Mali.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNational Institutes of Health · USNational Institute of Allergy and Infectious Diseases · US

Funding

Vaccines to Interrupt Malaria Transmission: Clinical DevelopmentZIAAI001009 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2009 to 2025
$84.8M
6 · The paper itself

Abstract

The interpretation of a laboratory test result requires an appropriate reference range established in healthy subjects, and normal ranges may vary by factors such as geographic region, sex, and age. We examined hematological and clinical chemistry parameters in healthy residents at two rural vaccine trial sites: Bancoumana and Doneguebougou in Mali, West Africa. During screening of clinical studies in 2018 and 2019, peripheral blood samples from 1,192 apparently healthy individuals age 6 months to 82 years were analyzed at a laboratory accredited by the College of American Pathologists for a complete blood count, and creatinine and/or alanine aminotransferase levels. Based on manufacturers' reference range values, which are currently used in Malian clinical laboratories, abnormal values were common in this healthy population. In fact, 30.4% of adult participants had abnormal neutrophil levels and 19.8% had abnormal hemoglobin levels. Differences by sex were observed in those who were older, but not in those younger than 10 years, for several parameters, including hemoglobin, platelet, and absolute neutrophil counts in hematology, and creatinine in biochemistry. The site-specific reference intervals we report can be used in malaria vaccine clinical trials and other interventional studies, as well as in routine clinical care, to identify abnormalities in hematological and biochemical parameters among healthy Malian trial participants.

Indexed as

Rural PopulationAdolescentAdultAgedAged, 80 and overAge FactorsBlood Cell CountChildChild, PreschoolCreatinineFemaleHemoglobinsHumansInfantLaboratories, ClinicalMaleCreatinineHemoglobins

Identifiers

PMID38531104
PMCPMC11066370
OpenAlexW4393188970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.